Insiders · Profile

Brady Kelly

See Remarks at Seres Therapeutics. Filing since 18 May 2026. CIK 0002117686

Company
Date
Role
Action
Shares
Amount
Of holding
17 Aug 2026
See Remarks
Sold on a plan
64
$291.20
0.7%
18 May 2026
See Remarks
Sold at will
59
$444.27
0.7%
2 decisions on file.